ALTMAN MICHAEL SETH 4
4 · Nautilus Biotechnology, Inc. · Filed Jun 17, 2022
Insider Transaction Report
Form 4
ALTMAN MICHAEL SETH
DirectorChief Financial Officer10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2022-06-15+86,467→ 86,467 totalExercise: $2.70Exp: 2032-06-15→ Common Stock (86,467 underlying)
Footnotes (1)
- [F1]Subject to the reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan) through each vesting date, the shares subject to the Option shall vest on a monthly basis for twelve consecutive months, on the same day of the month as the Grant Date. The Grant Date was June 15, 2022.